Jane Henderson's Net Worth

$12.1 Million

Estimate Recalculated Nov 11, 2024 08:52AM EST

Who is Jane Henderson?

Jane Henderson has an estimated net worth of $12.1 Million. This is based on reported shares across multiple companies, which include Adagio Therapeutics, Inc., Voyager Therapeutics, Inc., Akero Therapeutics, Inc., Ophthotech Corp., Eleven Biotherapeutics, Inc., PANACOS PHARMACEUTICALS, INC., Apogee Therapeutics, Inc., and CARGO Therapeutics, Inc..

SEC CIK

Jane Henderson's CIK is 0001422304

Past Insider Trading and Trends

2018 was Jane Henderson's most active year for acquiring shares with 8 total transactions. Jane Henderson's most active month to acquire stocks was the month of May. 2023 was Jane Henderson's most active year for disposing of shares, totalling 12 transactions. Jane Henderson's most active month to dispose stocks was the month of February. 2023 saw Jane Henderson paying a total of $280,400.00 for 252,433 shares, this is the most they've acquired in one year. In 2023 Jane Henderson cashed out on 242,862 shares for a total of $2,166,684.66, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adagio Therapeutics, Inc. (IVVD) Snapshot price: $0.822

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 30
Form 3
—
0
—
—
0
No matching records found

Voyager Therapeutics, Inc. (VYGR) Snapshot price: $6.13

Sr. V.P. & CFO, Corp. Dev.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$16.42
-$276,850.00
0
Mar 22 - Mar 23
Form 4
—
0
$17.04
-$175,535.88
0
Mar 16 - Mar 19
Form 4
—
0
—
—
0
Mar 7
Form 4
—
0
—
—
0
Jan 3
Form 3
—
0
—
—
0
No matching records found

Akero Therapeutics, Inc. (AKRO) Snapshot price: $26.41

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
$30.59
-$1,886,284.65
0
Jun 16
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 3
—
0
—
—
0
No matching records found

Ophthotech Corp. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-22.09K
—
—
0
Jul 11
Form 4
—
0
—
—
0
May 17
Form 4
+194.51%
14.59K
—
—
22.09K
May 11
Form 4
∞
7.5K
—
—
7.5K
May 11 - May 12
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
Jan 13
Form 3
—
0
—
—
0
No matching records found

Eleven Biotherapeutics, Inc. (CARM) Snapshot price: $0.9803

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 3
Form 4
—
0
—
—
0
May 6
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 16
Form 3
—
0
—
—
0
No matching records found